Cargando…
Role of 25-hydroxyvitamin D in irritable bowel syndrome patients
We conducted this study on patients diagnosed with irritable bowel syndrome without identifiable stressors and replaced them with vitamin D supplements for 3 months. Almost 97 cases have repeated the vitamin D status that appeared to be sufficient, while 14 patients were missing data for follow-up....
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041043/ https://www.ncbi.nlm.nih.gov/pubmed/36994062 http://dx.doi.org/10.4103/jfmpc.jfmpc_1336_22 |
_version_ | 1784912620640272384 |
---|---|
author | Alvi, Haris Ali, Gohar Iqbal, Sadia Ahsan, Muhammad Nadeem Avinash, Siddiqui, Muhammad Ali Kirmani, Tooba Ahmed Irshad, Ghazala Baktashi, Haisum Asghar, Muhammad Sohaib |
author_facet | Alvi, Haris Ali, Gohar Iqbal, Sadia Ahsan, Muhammad Nadeem Avinash, Siddiqui, Muhammad Ali Kirmani, Tooba Ahmed Irshad, Ghazala Baktashi, Haisum Asghar, Muhammad Sohaib |
author_sort | Alvi, Haris |
collection | PubMed |
description | We conducted this study on patients diagnosed with irritable bowel syndrome without identifiable stressors and replaced them with vitamin D supplements for 3 months. Almost 97 cases have repeated the vitamin D status that appeared to be sufficient, while 14 patients were missing data for follow-up. The advised option was intramuscular injection replacement but 34 out of 97 were taken oral route for replacement of Vitamin D and incidental finding is noted that serum vitamin D levels rise less in the oral group than in the intramuscular group. Mean age of our subjects was 35.97 ± 9.89 years, comprising 54% males (n = 60) and 46% females (n = 51). In the outcomes of our study, 56.7% of individuals showed complete relief from IBS symptoms after vitamin D replacement, while 36.1% reported considerable improvement. Another 6.2% had exhibited moderate relief with about 14 individuals lost to follow-up. |
format | Online Article Text |
id | pubmed-10041043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-100410432023-03-28 Role of 25-hydroxyvitamin D in irritable bowel syndrome patients Alvi, Haris Ali, Gohar Iqbal, Sadia Ahsan, Muhammad Nadeem Avinash, Siddiqui, Muhammad Ali Kirmani, Tooba Ahmed Irshad, Ghazala Baktashi, Haisum Asghar, Muhammad Sohaib J Family Med Prim Care Case Series We conducted this study on patients diagnosed with irritable bowel syndrome without identifiable stressors and replaced them with vitamin D supplements for 3 months. Almost 97 cases have repeated the vitamin D status that appeared to be sufficient, while 14 patients were missing data for follow-up. The advised option was intramuscular injection replacement but 34 out of 97 were taken oral route for replacement of Vitamin D and incidental finding is noted that serum vitamin D levels rise less in the oral group than in the intramuscular group. Mean age of our subjects was 35.97 ± 9.89 years, comprising 54% males (n = 60) and 46% females (n = 51). In the outcomes of our study, 56.7% of individuals showed complete relief from IBS symptoms after vitamin D replacement, while 36.1% reported considerable improvement. Another 6.2% had exhibited moderate relief with about 14 individuals lost to follow-up. Wolters Kluwer - Medknow 2022-12 2023-01-17 /pmc/articles/PMC10041043/ /pubmed/36994062 http://dx.doi.org/10.4103/jfmpc.jfmpc_1336_22 Text en Copyright: © 2023 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Series Alvi, Haris Ali, Gohar Iqbal, Sadia Ahsan, Muhammad Nadeem Avinash, Siddiqui, Muhammad Ali Kirmani, Tooba Ahmed Irshad, Ghazala Baktashi, Haisum Asghar, Muhammad Sohaib Role of 25-hydroxyvitamin D in irritable bowel syndrome patients |
title | Role of 25-hydroxyvitamin D in irritable bowel syndrome patients |
title_full | Role of 25-hydroxyvitamin D in irritable bowel syndrome patients |
title_fullStr | Role of 25-hydroxyvitamin D in irritable bowel syndrome patients |
title_full_unstemmed | Role of 25-hydroxyvitamin D in irritable bowel syndrome patients |
title_short | Role of 25-hydroxyvitamin D in irritable bowel syndrome patients |
title_sort | role of 25-hydroxyvitamin d in irritable bowel syndrome patients |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041043/ https://www.ncbi.nlm.nih.gov/pubmed/36994062 http://dx.doi.org/10.4103/jfmpc.jfmpc_1336_22 |
work_keys_str_mv | AT alviharis roleof25hydroxyvitamindinirritablebowelsyndromepatients AT aligohar roleof25hydroxyvitamindinirritablebowelsyndromepatients AT iqbalsadia roleof25hydroxyvitamindinirritablebowelsyndromepatients AT ahsanmuhammadnadeem roleof25hydroxyvitamindinirritablebowelsyndromepatients AT avinash roleof25hydroxyvitamindinirritablebowelsyndromepatients AT siddiquimuhammadali roleof25hydroxyvitamindinirritablebowelsyndromepatients AT kirmanitoobaahmed roleof25hydroxyvitamindinirritablebowelsyndromepatients AT irshadghazala roleof25hydroxyvitamindinirritablebowelsyndromepatients AT baktashihaisum roleof25hydroxyvitamindinirritablebowelsyndromepatients AT asgharmuhammadsohaib roleof25hydroxyvitamindinirritablebowelsyndromepatients |